Provided sample report
Cagrilintide 5 mg
Vanguard Laboratory · V250915-11 001
Read this document note
SOURCE FILENAME MISMATCH: file named glp-t-60-mg-2, but report title and compound explicitly Cagrilintide 5 mg. Do not associate with Tirzepatide 60 mg. Bottle label appears to mention a blend; report body only gives Cagrilintide.
- Sample
- Cagrilintide 5 mg
- Sample specification
- 5 mg
- Laboratory shown
- Vanguard Laboratory
- Submitting client shown
- Optimum Formula
- Report number
- V250915-11 001
- Sample lot / batch
- 3H9MY
- Date reported
- 2025-09-29
| Test shown | Method shown | Reported result |
|---|---|---|
| Chromatographic Purity | HPLC-UV/VIS | >99.80% ± 0.18% |
| Quantity | HPLC-UV/VIS | 5.89 mg |
| Endotoxins | LAL | Pass - 1.37 EU/mg* |
Results are transcribed from this sample report. The original document takes precedence; these results are not specifications or guarantees for other samples.
The submitting client is Optimum Formula. The connection between this sample lot and current NorthVerity inventory has not been established. Request the current lot document with your inquiry.
Related catalog entries
The links below are references based on catalog naming. Confirm the chemical form, blend composition, specification and current inventory lot separately.
Original-file fingerprint
SHA-256: a07496ab960b724c2e3b273450f1fa31d89508f999d0d6095b3fb36f2b598347